GD
Ramsay Générale de Santé S.A.
GDS.PA · PAR
10.70 € +0.47% (+0.05 €)
1M +0.47%
Market Cap 1.18B €
P/E Ratio -
Div. Yield -
ROE 4.25%
Bulios Fair Price
11.64 €
8.8% upside
Current Price
10.7 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GDS.PA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
98 /100
Cheap P/B 1.05x
EV/EBITDA 7.81x
P/FCF 3.36x
Growth
26 /100
Declining Book val. growth 3.47%
Rev. growth 4.60%
FCF growth 3.72%
Profitability
39 /100
Moderate Op. margin 3.66%
Gross margin 78.62%
FCF margin 6.51%
Quality
40 /100
Average ROA 0.72%
ROIC 13.59%
Asset turnover 0.81x
Debt
6 /100
High Int. coverage 0.90x
Debt/Equity 3.60x
Net debt/EBITDA 5.94x
Stability
33 /100
Unstable EPS volatility 157.61%
Beta 0.24x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GDS.PA
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Pascal Roche
Employees
40,000
Headquarters
Paris
Upcoming events
16 OCT
Earnings
Upcoming earnings report